Almac

What Offers to Clients:

• Accelerated development to phase
  • Typically 12 months from lab synthesis to CTA submission
• Flexible solutions tailored to client requirements
  • Small molecules or peptide
• Integrated CMC & pre-clinical safety activities
• Simplified communication
  • Single contract
  • Dedicated programme management support

Benefits of

• Lead candidate to phase I regulatory submission in 12 months
  • Reduce cash-burn
  • Realise milestones earlier
  • Gain competitive advantage through the acceleration of your drug candidate programme
• Focus on adding value to your business through your core competences and reduce the effort spent on auditing, coordinating and managing multiple vendors